Status:
COMPLETED
Vienna Absolute Trial: Balloon Angioplasty Versus Stenting in the Superficial Femoral Artery
Lead Sponsor:
Medical University of Vienna
Conditions:
Atherosclerosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Minimal invasive treatment (called "endovascular") of the arteries of the lower limb remains problematic, because recurrent disease ("restenosis") frequently leads to recurrent symptoms. As yet, ballo...
Detailed Description
STUDY DESIGN. From June 2003 to August 2004, we screened consecutive patients referred for endovascular treatment of the SFA due to intermittent claudication or chronic critical limb ischemia for enro...
Eligibility Criteria
Inclusion
- Symptomatic peripheral artery disease Rutherford stages 3 to 5
- \>50% stenosis of the ipsilateral superficial femoral artery
- Lesion length \>30mm
- At least one patent crural run-off vessel,
Exclusion
- Acute criticla limb ischemia
- Previous ipsilateral bypass surgery or ipsilateral SFA stenting
- Untreated inflow disease
- Known intolerance to clopidogrel, aspirin or radiocontrast
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
End Date :
August 1 2005
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00281060
Start Date
June 1 2003
End Date
August 1 2005
Last Update
July 27 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University Vienna
Vienna, Vienna, Austria, A 1090